Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2352 of 6351
-
Can a single protein explain Asthma's many faces?
Knowledge-focused Recruiting nowAsthma is a heterogeneous disease characterized by chronic airway inflammation, leading to variable airflow obstruction, bronchial hyperresponsiveness, excessive mucus secretion, and, consequently, structural airway remodeling. Asthma is defined by the presence of symptoms such a…
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Dry eye drops may sharpen cataract surgery outcomes
Disease control CompletedA Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy
Phase 4 • Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can special goggles help Parkinson's patients see and feel better?
Symptom relief By invitation onlyThe aim of the study is to investigate whether prismatic adaptation (PA) and virtual prismatic adaptation (VPA), a non-invasive neuromodulation technique, that involves the use of lenses that deviate the visual field, can modulate alexithyima and performance in visuospatial tasks…
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Cancer patients may soon get immunotherapy at home instead of the clinic
Symptom relief Recruiting nowThis phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setting on cancer care and quality of life. Currently, most drug-related cancer care is conducted in clinic type centers or hospitals which may isolate patients from…
Phase 2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedA Multicenter, Phase 3, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Environment Exposure Clinical Trial to Assess the Efficacy and Safety of 0.25% Reproxalap
Phase 3 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New pill aims to stop muscle loss during Weight-Loss drug boom
Disease control CompletedThe primary objective of this study is to assess the effect of enobosarm on total lean mass as measured by DEXA in patients maintained on GLP-1 receptor agonists.
Phase 2 • Sponsor: Veru Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:57 UTC
-
Brain zaps may boost PTSD therapy by calming fear response
Knowledge-focused Recruiting nowThis study will be the first of its kind to explore the impact of continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) on arousal symptoms among patients with posttraumatic stress disorder (PTSD). The investigators will demonstrate that IPS cTBS results in …
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Opioid-Free anesthesia: a safer way to go under the knife?
Symptom relief Recruiting nowOpioid-free anesthesia (OFA) is a multimodal technique that eliminates intraoperative opioids by combining dexmedetomidine, ketamine, lidocaine, NSAIDs, and regional analgesia. Growing evidence suggests OFA reduces postoperative opioid consumption, opioid-related adverse effects,…
Sponsor: Jagiellonian University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
A safer first cut? trial tests two laparoscopic entry points for endometrial cancer surgery
Disease control CompletedThis randomized controlled trial compares Lee-Huang point entry with conventional umbilical entry for laparoscopic surgery in patients with endometrial cancer. The study aims to evaluate the success of abdominal entry, entry-related complications, operative outcomes, and perioper…
Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Group therapy program aims to ease anxiety and depression in public health settings
Symptom relief Recruiting nowThis study has three primary objectives: 1. To adapt the Spanish version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP; Barlow et al., 2011, 2019a, 2019b) for delivery in a group format within the Spanish Public Mental Health System for adults …
Sponsor: Patricia Fernández Couto • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a natural thyroid extract replace synthetic hormones for hypothyroidism?
Disease control Recruiting nowThis study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid-stimulating hormone \[TSH\]) on synthetic T4 treatment. This study will also th…
Phase 2/3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Orange juice study could unlock secrets of gut health
Knowledge-focused CompletedThis study will provide a greater insight into the relationship between orange consumption and health (particularly gut health) and could be used to help with the development of novel food products. Oranges are a rich source of (poly)phenols, and although the advantages of a (pol…
Sponsor: University of Ulster • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could two weeks of therapy beat six months for anxiety?
Symptom relief OngoingThe goal of this clinical trial is to compare brief-intensive cognitive-behaviour therapy (CBT) with regular weekly CBT in people with anxiety-related disorders. The main question to answer is: will brief-intensive CBT improve functioning (work, family, social) more and faster t…
Sponsor: Amsterdam UMC, location VUmc • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could babies with mild hip dysplasia skip the brace?
Disease control Recruiting nowDevelopmental dysplasia of the hip (DDH) is the most common childhood hip condition. When caught early, bracing is the most frequently used treatment; however, the brace can disrupt important mother-baby bonding time in the newborn period and present challenges to daily living. I…
Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Pacemaker vs. pills: which works better for irregular heartbeat and heart failure?
Disease control Recruiting nowAtrial fibrillation (AF) is an irregular heartbeat that can cause symptoms of skipped beats, shortness of breath, stroke, or in some cases fluid in the lungs or legs. Treating AF is mostly to do with slowing the heart rate down so that the heart can get a chance to regain some en…
Sponsor: Habib Khan • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
App aims to boost cancer patients' well-being at home
Symptom relief CompletedFEGALA is a comparative, multicenter, randomized, prospective, open-label study comparing the results observed at 3 months (± 15 days) on the EORTC QLQ-C30 scale in a group of patients with metastatic cancer followed on an outpatient basis and benefiting from the CONTINUUM+ CONNE…
Sponsor: Centre Paul Strauss • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Can emergency heart data travel safely through the air?
Knowledge-focused CompletedA multicenter, prospective and retrospective, observational, post market study.
Sponsor: Heartstream US LLC • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Could a common antibiotic replace stronger drugs for pneumonia in seniors?
Disease control Recruiting nowReduce inappropriate antibiotic use is a priority of public health agencies. Community-acquired pneumonia (CAP) is one of the most important indications for antibiotic prescriptions. In the majority of the studies of CAP, there is a large proportion of cases with no pathogen ide…
Phase 3 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New stent aims to prevent stroke in patients with clogged neck arteries
Disease control OngoingThe purpose of this trial is to evaluate effectiveness and safety of the Ton-bridge carotid stent for the treatment of carotid artery stenosis.
Sponsor: Ton-Bridge Medical Tech. Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New brain aneurysm device tracked for 5 years in 500 patients
Disease control OngoingA prospective, multi-center, single-arm, open-label, observational, post-market clinical follow-up. The expected duration of the study is 8 years (including up to 5-years' follow-up). Each subject will be followed up per standard of care (SoC) at each study site.
Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC